Location History:
- 8102 Oberengstrigen, CH (1988)
- 00 Lund, SE (1990)
- 20 Furulund, SE (1992)
- CH-8102 Oberengstringen, CH (1993)
- 8102 Oberengstringen, CH (1994)
- P1 94 Furulund, SE (1995)
- 02 Furulund, SE (1985 - 1999)
- 8057, Zurich, CH (1998 - 1999)
- Furulund 24402, SE (2000)
- 94 Furulund, SE (2001 - 2002)
- SE-244 94 Furulund, SE (2006)
- Furulund, SE (1985 - 2007)
Company Filing History:
Years Active: 1985-2007
Title: **Innovative Contributions of Klaus Mosbach in the Field of Artificial Antibodies**
Introduction
Klaus Mosbach, based in Furulund, Sweden, is a distinguished inventor with a notable portfolio comprising 21 patents. His innovative work primarily focuses on advancements in the field of artificial antibodies, which have significant implications in therapeutic and diagnostic applications.
Latest Patents
Mosbach's recent patents revolve around the creation and application of artificial antibodies, which are polymer-based constructs designed to emulate the properties of natural antibodies. One of his key patents outlines a method for producing these artificial antibodies by polymerizing monomers with specific functional groups in the presence of a print molecule. After polymerization, the print molecule is removed, resulting in unique binding sites tailored to attach to specific organic molecules. Additionally, his work on selective affinity materials employs molecular imprinting techniques to create cavities in polymers that are specifically shaped for target biological molecules, enhancing the isolation and determination process of these molecules.
Career Highlights
Throughout his career, Klaus Mosbach has significantly contributed to the field of biochemistry and molecular biology, particularly through his work on artificial antibodies. His innovative approaches have opened pathways for the development of new therapeutic methods, showcasing the versatility and potential of polymer chemistry in medical applications.
Collaborations
In his professional journey, Mosbach has collaborated with notable figures in the industry, including Andrew G. Mayes and Olof Ramström. These collaborations reflect a synergistic approach to innovation, further advancing the boundaries of scientific research and practical applications in the realm of artificial antibodies.
Conclusion
Klaus Mosbach's inventions reflect a profound understanding of molecular interactions and the potential of synthetic materials in biomedical applications. His contributions, particularly in creating and utilizing artificial antibodies, represent a significant advancement in the field, promising transformative impacts on diagnostics and therapeutics. As he continues to innovate, Mosbach's work will undoubtedly inspire future research and technological developments within the scientific community.